Clinical Trials Logo

Contrast Media Adverse Reaction clinical trials

View clinical trials related to Contrast Media Adverse Reaction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05489055 Recruiting - Clinical trials for Contrast Media Adverse Reaction

Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Extrinsic prewarming of iodinated CT contrast media (CM) to body temperature reduces viscosity and injection pressures. However, guideline recommendations on the necessity to prewarm iodinated CM are conflicting. And studies examining the effect of extrinsic warming CM for coronary CTA(CCTA) on clinical adverse events and image quality are lack. Enrolled patients of chest pain or coronary artery disease screening were eligible for this a double-blinded, randomized noninferiority trial, and equally allocated into two group randomly: BBT-CM (basic body temperature) group received 37°C CM; RT-CM (room temperature) group received ~23°C CM. A state-of-the-art individualized CM (iopamidol at 370 mg I/mL) injection protocol was used, based on body weight.